Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05239858 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

International Wilson's Disease Patient Registry (iWilson Registry)

StatusRecruiting
PhaseNot specified
SponsorOrphalan
Started
View on ClinicalTrials.gov ↗

Record History

  1. 2 versions Re-verified since Jun 30, 2025, no change to tracked fieldsv11-v12
  2. Site contacts updated at 1 of 16 sitesv10
  3. 2 versions Re-verified since Apr 29, 2024, no change to tracked fieldsv8-v9
  4. Study sites: 15 to 16v7
  5. Re-verified, no change to tracked fieldsv6
Show 4 earlier versionsHide 4 earlier versions
  1. Study sites: 14 to 15v5
  2. Re-verified, no change to tracked fieldsv4
  3. Primary completion date: Jan 2023 to Dec 2027
    • Study completion date: Jan 2027 to Dec 2027
    • Site details revised at 9 of 14 sites
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 2022 to Jun 29, 2022
    • Study sites: 1 to 14
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Orphalan
5 trials monitored
See all monitored trials
Longitudinal, observational, non-interventional, standard of care Registry. Data will be collected from the routinely scheduled WD clinic visits at approximately 6-12 month intervals. At enrolment, in addition to data from the clinic visit, retrospective data will be collected from the diagnostic evaluation and any relevant past medical history and a summary of WD medication history.
Trial Details
NCT Number NCT05239858
Lead Sponsor Orphalan
Collaborators: Ergomed
Conditions
(from sponsor)		 Wilson's Disease
Related terms Hepatolenticular Degeneration
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov